Table 2.
The response and effects of neoadjuvant chemotherapy
| Characteristic | Number of patients | Percent (%) |
|---|---|---|
| Response of Primary tumor | ||
| CR | 3 | 6.5 |
| PR | 34 | 73.9 |
| SD | 7 | 15.2 |
| PD | 2 | 4.4 |
| Response of PAL | ||
| CR | 8 | 17.4 |
| PR | 27 | 58.7 |
| SD | 9 | 19.6 |
| PD | 2 | 4.4 |
| Adverse Events (grade 3/4) | ||
| Anemia | 3 | 6.5 |
| Leukopenia | 3 | 6.5 |
| Thrombocytopenia | 2 | 4.3 |
| Hepatic inadequacy | 0 | 0 |
| Renal dysfunction | 0 | 0 |
| Nausea | 6 | 13.0 |
| Vomiting | 5 | 10.9 |
| Diarrhea | 3 | 6.5 |
CR complete response; PR partial response; SD stable disease; PD progressive disease